Memorias do Instituto Oswaldo Cruz

Papers
(The median citation count of Memorias do Instituto Oswaldo Cruz is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease25
The translational challenge in Chagas disease drug development24
Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-202123
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy21
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells19
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission18
Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory13
Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America11
Family Herpesviridae and neuroinfections: current status and research in progress11
Emerging and reemerging forms of Trypanosoma cruzi transmission11
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field11
Perspectives for a new drug candidate for Chagas disease therapy11
Prognosis of chronic Chagas heart disease and other pending clinical challenges10
Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives10
Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil10
Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi10
Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis9
Why do we still have not a vaccine against Chagas disease?9
Chagas disease in the context of the 2030 agenda: global warming and vectors9
Population movements, borders, and Chagas disease9
Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis8
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target8
Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy8
Computational approaches towards the discovery and optimisation of cruzain inhibitors8
Mycolicibacterium fortuitum genomic epidemiology, resistome and virulome7
Urban infestation by Triatoma infestans (Hemiptera: Reduviidae), an overlooked phenomena for Chagas disease in Argentina7
A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review6
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection6
Mechanism of action of glycyrrhizin against Plasmodium falciparum6
Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations6
Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts6
Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening6
Flight tone characterisation of the South American malaria vector Anopheles darlingi (Diptera: Culicidae)6
Is the mitochondrion a promising drug target in trypanosomatids?6
Differential expression profiles of miRNAs and their putative targets in Schistosoma mansoni during its life cycle5
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease5
Antigenicity and adhesiveness of a Plasmodium vivax VIR-E protein from Brazilian isolates5
Epidemiology of paracoccidioidomycosis in Venezuela: a retrospective study from 1954 to 20195
An emerging paradigm for the origin and evolution of shelled amoebae, integrating advances from molecular phylogenetics, morphology and paleontology5
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*5
Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion5
Critical analysis of Chagas disease treatment in different countries5
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day5
Sand fly behavior: much more than weak-flying4
Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil4
Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama4
The adaptation of SARS-CoV-2 to humans4
Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’4
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon4
Enterovirus infection and its relationship with neurodegenerative diseases4
Should COVID-19 be branded to viral thrombotic fever?4
Detection of non-tuberculosus mycobacteria (NTMs) in lung samples using 16S rRNA4
Multidisciplinary approach detects speciation within the kissing bug Panstrongylus rufotuberculatus populations (Hemiptera, Heteroptera, Reduviidae)4
Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain4
Giardiasis in urban and rural Amazonas, Brazil is driven by zoonotic and cosmopolitan A and B assemblages3
Molecular aspects of Chikungunya virus infections in cancer patients3
Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry3
Suitability of methods for Plasmodium falciparum cultivation in atmospheric air3
How is global change affecting Chagas disease landscapes?3
A short history of innate immunity3
Cerebrospinal fluid: a target of some fungi and an overview3
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole3
Reemergence of human malaria in Atlantic Forest of Rio Grande do Sul, Brazil3
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment3
Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis3
Chagas disease treatment: a 120-year-old challenge to public health3
Callitrichine gammaherpesvirus 3 and Human alphaherpesvirus 1 in New World Primate negative for yellow fever virus in Rio de Janeiro, Brazil3
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil3
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon3
Article-processing charges as a barrier for science in low-to-medium income regions3
Lipid droplets of protozoan parasites: survival and pathogenicity3
First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil3
A new Trypanosoma cruzi genotyping method enables high resolution evolutionary analyses3
First report and genome sequencing of SARS-CoV-2 in a cat (Felis catus) in Colombia3
Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG2
Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells2
In vitro activity of Schinus terebinthifolius extract and fractions against Sporothrix brasiliensis2
Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection2
Giardia lamblia-infected preschoolers present growth delays independent of the assemblage A, B or E2
Mitochondrial dysfunction on Leishmania (Leishmania) amazonensis induced by ketoconazole: insights into drug mode of action2
Revisiting trypanosomatid nucleoside diphosphate kinases2
Different profiles and epidemiological scenarios: past, present and future2
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved*2
COVID-19 diagnosis by RT-qPCR in alternative specimens2
The history of Chagas disease: reflections on science in action2
Expansion of T regulatory lymphocytes by murine bone marrow dendritic cells previously stimulated with Anisakis simplex larval antigens2
Identification and characterisation of SARS-CoV-2 and Human alphaherpesvirus 1 from a productive coinfection in a fatal COVID-19 case2
Electrochemical immunosensor for detection of Plasmodium vivax lactate dehydrogenase2
Transcriptome comparison of dengue-susceptible and -resistant field derived strains of Colombian Aedes aegypti using RNA-sequencing2
HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics2
Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review2
Characterising four Sarconesiopsis magellanica (Diptera: Calliphoridae) larval fat body-derived antimicrobial peptides2
Chagas disease affects the human placental barrier’s turnover dynamics during pregnancy2
The gene expression of Leishmania infantum chagasi inside Lutzomyia longipalpis, the main vector of visceral leishmaniasis in Brazil2
Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil2
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors1
Intravenous whole blood transfusion results in faster recovery of vascular integrity and increased survival in experimental cerebral malaria1
Unveiling the genome of a high-risk pandrug-resistant Klebsiella pneumoniae emerging in the Brazilian Amazon Region, 20221
The scientific publication of the Memórias do Instituto Oswaldo Cruz (1909-2020): a history of contribution to the biomedical sciences1
Air in the tires: towards an achievable, efficacious and timely diagnosis for Chagas disease1
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress1
Molecular mechanisms of action of trypanocidal and leishmanicidal drugs with focus on novel chemotherapeutic strategies: creation of a Brazilian multicentre working group1
Lack of serological and molecular evidences of Zika virus circulation in non-human primates in three states from Brazil1
The challenges for targeting Chagas disease for elimination as a public health problem1
Past and future of trypanosomatids high-throughput phenotypic screening1
Vitellogenin genes are transcribed in Culex quinquefasciatus ovary1
Stronger control-surveillance systems for vector-borne Chagas disease1
Primary infection of BALB/c mice with a dengue virus type 4 strain leads to kidney injury1
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat1
Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing1
Mapping Yellow fever epidemics as a potential indicator of the historical range of Aedes aegypti in the United States1
Pathophysiology and new targets for therapeutic options in Chagas heart disease1
Open-source real-time quantitative RT-PCR-based on a RNA standard for the assessment of SARS-CoV-2 viral load1
A straightforward one-step strategy for SARS-CoV-2 diagnosis and screening of variants of concern: a multicentre study1
Tracing the relationship among HIV-1 sub-subtype F1 strains: a phylodynamic perspective1
Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes1
Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide1
Insecticide resistance levels and associated mechanisms in three Aedes aegypti populations from Venezuela1
The challenge of risk assessment in the riddle of Chagas heart disease1
Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains1
A review of serological tests available in Brazil for intestinal schistosomiasis diagnosis1
Perillyl alcohol modulates activation, permeability and integrity of human brain endothelial cells induced by Plasmodium falciparum1
Comment on “The translational challenge in Chagas disease drug development” by Kratz et al.1
Trypanosoma cruzi and Chagas disease: diversity, progress and challenges1
Clinically silent Plasmodium vivax infections in native Amazonians of northwestern Brazil: acquired immunity or low parasite virulence?1
Reflections on Chagas disease in the Amazon1
Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography1
First report of Leishmania (Mundinia) martiniquensis in South American territory and confirmation of Leishbunyavirus infecting this parasite in a mare1
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease1
Plasmodium vivax metacaspase 1 (PvMCA1) catalytic domain is conserved in field isolates from Brazilian Amazon1
Presence of trypanosomatids, with emphasis on Leishmania, in Rodentia and Didelphimorphia mammals of a rural settlement in the central Amazon region1
An updated gene regulatory network reconstruction of multidrug-resistant Pseudomonas aeruginosa CCBH48511
Immunoanalysis of different antigenic preparations of Angiostrongylus cantonensis for neuroangiostrongyliasis diagnosis improvement1
Brazilian science: towards extinction?1
Molecular diversity of genes related to biological rhythms (period and timeless) and insecticide resistance (Na V and ace-1) in Anopheles darlingi1
0.029176950454712